Cargando…
Modeling Hepatotropic Viral Infections: Cells vs. Animals
The lack of an appropriate platform for a better understanding of the molecular basis of hepatitis viruses and the absence of reliable models to identify novel therapeutic agents for a targeted treatment are the two major obstacles for launching efficient clinical protocols in different types of vir...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8305759/ https://www.ncbi.nlm.nih.gov/pubmed/34359899 http://dx.doi.org/10.3390/cells10071726 |
_version_ | 1783727649026211840 |
---|---|
author | Khoshdel-Rad, Niloofar Zahmatkesh, Ensieh Bikmulina, Polina Peshkova, Maria Kosheleva, Nastasia Bezrukov, Evgeny A. Sukhanov, Roman B. Solovieva, Anna Shpichka, Anastasia Timashev, Peter Vosough, Massoud |
author_facet | Khoshdel-Rad, Niloofar Zahmatkesh, Ensieh Bikmulina, Polina Peshkova, Maria Kosheleva, Nastasia Bezrukov, Evgeny A. Sukhanov, Roman B. Solovieva, Anna Shpichka, Anastasia Timashev, Peter Vosough, Massoud |
author_sort | Khoshdel-Rad, Niloofar |
collection | PubMed |
description | The lack of an appropriate platform for a better understanding of the molecular basis of hepatitis viruses and the absence of reliable models to identify novel therapeutic agents for a targeted treatment are the two major obstacles for launching efficient clinical protocols in different types of viral hepatitis. Viruses are obligate intracellular parasites, and the development of model systems for efficient viral replication is necessary for basic and applied studies. Viral hepatitis is a major health issue and a leading cause of morbidity and mortality. Despite the extensive efforts that have been made on fundamental and translational research, traditional models are not effective in representing this viral infection in a laboratory. In this review, we discuss in vitro cell-based models and in vivo animal models, with their strengths and weaknesses. In addition, the most important findings that have been retrieved from each model are described. |
format | Online Article Text |
id | pubmed-8305759 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-83057592021-07-25 Modeling Hepatotropic Viral Infections: Cells vs. Animals Khoshdel-Rad, Niloofar Zahmatkesh, Ensieh Bikmulina, Polina Peshkova, Maria Kosheleva, Nastasia Bezrukov, Evgeny A. Sukhanov, Roman B. Solovieva, Anna Shpichka, Anastasia Timashev, Peter Vosough, Massoud Cells Review The lack of an appropriate platform for a better understanding of the molecular basis of hepatitis viruses and the absence of reliable models to identify novel therapeutic agents for a targeted treatment are the two major obstacles for launching efficient clinical protocols in different types of viral hepatitis. Viruses are obligate intracellular parasites, and the development of model systems for efficient viral replication is necessary for basic and applied studies. Viral hepatitis is a major health issue and a leading cause of morbidity and mortality. Despite the extensive efforts that have been made on fundamental and translational research, traditional models are not effective in representing this viral infection in a laboratory. In this review, we discuss in vitro cell-based models and in vivo animal models, with their strengths and weaknesses. In addition, the most important findings that have been retrieved from each model are described. MDPI 2021-07-08 /pmc/articles/PMC8305759/ /pubmed/34359899 http://dx.doi.org/10.3390/cells10071726 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Khoshdel-Rad, Niloofar Zahmatkesh, Ensieh Bikmulina, Polina Peshkova, Maria Kosheleva, Nastasia Bezrukov, Evgeny A. Sukhanov, Roman B. Solovieva, Anna Shpichka, Anastasia Timashev, Peter Vosough, Massoud Modeling Hepatotropic Viral Infections: Cells vs. Animals |
title | Modeling Hepatotropic Viral Infections: Cells vs. Animals |
title_full | Modeling Hepatotropic Viral Infections: Cells vs. Animals |
title_fullStr | Modeling Hepatotropic Viral Infections: Cells vs. Animals |
title_full_unstemmed | Modeling Hepatotropic Viral Infections: Cells vs. Animals |
title_short | Modeling Hepatotropic Viral Infections: Cells vs. Animals |
title_sort | modeling hepatotropic viral infections: cells vs. animals |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8305759/ https://www.ncbi.nlm.nih.gov/pubmed/34359899 http://dx.doi.org/10.3390/cells10071726 |
work_keys_str_mv | AT khoshdelradniloofar modelinghepatotropicviralinfectionscellsvsanimals AT zahmatkeshensieh modelinghepatotropicviralinfectionscellsvsanimals AT bikmulinapolina modelinghepatotropicviralinfectionscellsvsanimals AT peshkovamaria modelinghepatotropicviralinfectionscellsvsanimals AT koshelevanastasia modelinghepatotropicviralinfectionscellsvsanimals AT bezrukovevgenya modelinghepatotropicviralinfectionscellsvsanimals AT sukhanovromanb modelinghepatotropicviralinfectionscellsvsanimals AT solovievaanna modelinghepatotropicviralinfectionscellsvsanimals AT shpichkaanastasia modelinghepatotropicviralinfectionscellsvsanimals AT timashevpeter modelinghepatotropicviralinfectionscellsvsanimals AT vosoughmassoud modelinghepatotropicviralinfectionscellsvsanimals |